Medicure (MCUJF) Total Non-Current Liabilities (2009 - 2026)
Medicure's (MCUJF) quarterly Total Non-Current Liabilities came in at $253763.6 in Q1 2026, down 18.36% year-on-year from $310824.7 in Q1 2025, and down 17.12% quarter-over-quarter from $306195.8 in Q4 2025.
Medicure (MCUJF) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Medicure's Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $253763.6 for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 18.36% year-over-year to $253763.6 in Q1 2026; TTM through Mar 2026 was $253763.6, a 18.36% decrease from a year earlier, with the FY2025 full-year figure at $305613.1, down 17.31% from the prior year.
- Total Non-Current Liabilities declined to $253763.6 in Q1 2026 per MCUJF's latest filing, from $306195.8 in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $1.1 million in Q1 2022 and bottomed at $136723.3 in Q2 2024.
- The 5-year median for Total Non-Current Liabilities is $339035.0 (2024), against an average of $433540.6.
- Across the five-year window, Total Non-Current Liabilities tumbled 79.85% in 2023 and jumped 222.52% in 2025, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $370561.6 in 2022, then slumped by 54.61% to $168208.6 in 2023, then jumped by 115.34% to $362219.7 in 2024, then slipped by 15.47% to $306195.8 in 2025, then retreated by 17.12% to $253763.6 in 2026.
- Per Business Quant, the three latest MCUJF Total Non-Current Liabilities figures stand at $253763.6 (Q1 2026), $306195.8 (Q4 2025), and $377850.2 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 14.92 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 18.28 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 33.47 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 20.09 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.24 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.26 Bn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 253,763.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253,763.58 |
| Dec 31, 2025 | 306,195.84 |
| Sep 30, 2025 | 377,850.20 |
| Jun 30, 2025 | 440,966.34 |
| Mar 31, 2025 | 310,824.75 |
| Dec 31, 2024 | 362,219.67 |
| Sep 30, 2024 | 407,577.70 |
| Jun 30, 2024 | 136,723.28 |
| Mar 31, 2024 | 155,843.77 |
| Dec 31, 2023 | 168,208.64 |
| Sep 30, 2023 | 205,130.88 |
| Mar 31, 2023 | 315,850.35 |
| Dec 31, 2022 | 370,561.58 |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 1.18 Mn |
| Sep 30, 2021 | 1.81 Mn |
| Jun 30, 2021 | 1.91 Mn |
| Mar 31, 2021 | 1.96 Mn |